As of 2024-12-12, the Intrinsic Value of IDEXX Laboratories Inc (IDXX) is
490.37 USD. This IDXX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 437.18 USD, the upside of IDEXX Laboratories Inc is
12.20%.
The range of the Intrinsic Value is 298.87 - 1,477.95 USD
490.37 USD
Intrinsic Value
IDXX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
298.87 - 1,477.95 |
490.37 |
12.2% |
| DCF (Growth 10y) |
371.56 - 1,723.69 |
592.44 |
35.5% |
| DCF (EBITDA 5y) |
274.64 - 449.19 |
359.16 |
-17.8% |
| DCF (EBITDA 10y) |
347.57 - 576.65 |
453.88 |
3.8% |
| Fair Value |
197.01 - 197.01 |
197.01 |
-54.94% |
| P/E |
363.30 - 453.86 |
391.84 |
-10.4% |
| EV/EBITDA |
188.12 - 360.79 |
301.42 |
-31.1% |
| EPV |
108.33 - 149.66 |
129.00 |
-70.5% |
| DDM - Stable |
140.59 - 890.50 |
515.55 |
17.9% |
| DDM - Multi |
238.80 - 1,174.96 |
396.80 |
-9.2% |
IDXX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
35,796.30 |
| Beta |
1.22 |
| Outstanding shares (mil) |
81.88 |
| Enterprise Value (mil) |
36,361.56 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.17% |
| Cost of Debt |
4.25% |
| WACC |
7.07% |